Bevacizumab-Induced Hypertension as a Potential Physiological Clinical Biomarker for Improved Outcomes in Patients With Recurrent Glioblastoma Multiforme: A Systematic Review
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.